1.4200
-0.0600
(-4.05%)
As of 11:29:37 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-10,263.6000
-10,263.6000
13,144.8000
8,214.3000
-1,104.9000
Investing Cash Flow
-2,027.9000
-2,027.9000
-3,300.4000
-1.4000
-316.4000
Financing Cash Flow
-2,372.2000
-2,372.2000
-6,602.7000
18,641.7000
1,847.8000
End Cash Position
16,596.3000
16,596.3000
31,260.0000
28,018.3000
1,163.7000
Capital Expenditure
--
--
-3,306.0000
-1.4000
-0.5000
Issuance of Capital Stock
--
--
--
19,895.8000
1,866.1000
Repayment of Debt
--
--
-150.0000
-1,201.8000
--
Repurchase of Capital Stock
-438.5000
-438.5000
--
--
--
Free Cash Flow
-10,263.6000
-10,263.6000
9,838.8000
8,212.9000
-1,105.4000
12/31/2020 - 10/14/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EZB.BE Enzo Biochem Inc
0.6300
-2.33%
IDHCl.XC
ESF0.MU Eurofins Scientific SE
50.22
0.00%
MVF.AX Monash IVF Group Limited
1.2150
+0.83%
VIMIAN.ST Vimian Group AB (publ)
38.40
+2.81%
DAP.DE Danaher Corporation
237.95
+1.21%
PRM.L Proteome Sciences plc
3.6200
-14.82%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%
DAP.F Danaher Corporation
237.40
+1.22%
AGL.L ANGLE plc
11.25
+1.12%